{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:17:42Z","timestamp":1791656262980,"version":"4.3.4"},"reference-count":186,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neurological diseases like Alzheimer\u2019s disease, epilepsy, parkinsonism, depression, Huntington\u2019s disease and amyotrophic lateral sclerosis prevailing globally are considered to be deeply influenced by oxidative stress-based changes in the biochemical settings of the organs. The excess oxygen concentration triggers the production of reactive oxygen species, and even the intrinsic antioxidant enzyme system, i.e. SOD, CAT and GSHPx, fails to manage their levels and keep them under desirable limits. This consequently leads to oxidation of protein, lipids and nucleic acids in the brain resulting in apoptosis, proteopathy, proteasomes and mitochondrion dysfunction, glial cell activation as well as neuroinflammation. The present exploration deals with the evidence-based mechanism of oxidative stress towards development of key neurological diseases along with the involved biomechanistics and biomaterials.<\/jats:p>","DOI":"10.1515\/hsz-2017-0250","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T17:16:12Z","timestamp":1513790172000},"page":"305-319","source":"Crossref","is-referenced-by-count":29,"title":["Biomechanistic insights into the roles of oxidative stress in generating complex neurological disorders"],"prefix":"10.1515","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-7774","authenticated-orcid":false,"given":"Mohammad","family":"Yusuf","sequence":"first","affiliation":[{"name":"College of Pharmacy , Taif University , Taif-Al-Haweiah 21974 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Khan","sequence":"additional","affiliation":[{"name":"College of Pharmacy , Taif University , Taif-Al-Haweiah 21974 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed A.","family":"Robaian","sequence":"additional","affiliation":[{"name":"College of Pharmacy , Taif University , Taif-Al-Haweiah 21974 , Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Department , Qassim University , Qassim 51452 , Saudi Arabia"},{"name":"Department of Chemistry, MRIU , Faridabad, HR 121 001 , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2017,12,20]]},"reference":[{"key":"2026080509241277460_j_hsz-2017-0250_ref_001_w2aab3b7c33b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Adibhatla, R.M. and Hatcher, J.F. (2007). Role of lipids in brain injury and diseases. Future Lipidol. 2, 403\u2013422.","DOI":"10.2217\/17460875.2.4.403"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_002_w2aab3b7c33b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Adibhatla, R.M., Hatcher, J.F., and Dempsey, R.J. (2006). Lipids and lipidomics in brain injury and diseases. AAPS J. 8, E314\u2013E321.","DOI":"10.1007\/BF02854902"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_003_w2aab3b7c33b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Aliev, G., Obrenovich, M.E., Tabrez, S., Jabir, N.R., Reddy, V.P., Li, Y., Burnstock, G., Cacabelos, R., and Kamal, M.A. (2013). Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA over-proliferation and deletion. Oxid. Med. Cell. Longev. 2013, 962984.","DOI":"10.1155\/2013\/962984"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_004_w2aab3b7c33b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Allsop, D., Mayes, J., Moore, S., Masad, A., and Tabner, B.J. (2008). Metal-dependent generation of reactive oxygen species from amyloid proteins implicated in neurodegenerative disease. Biochem. Soc. Trans. 36, 1293\u20131298.","DOI":"10.1042\/BST0361293"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_005_w2aab3b7c33b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Anandatheerthavarada, H.K. and Devi, L. (2007). Amyloid precursor protein and mitochondrial dysfunction in Alzheimer\u2019s disease. Neurosci. 13, 626\u2013638.","DOI":"10.1177\/1073858407303536"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_006_w2aab3b7c33b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Anggono, V., Li-Huei T., and G\u00f6tz, J. (2016). Glutamate receptors in Alzheimer\u2019s disease: mechanisms and therapies. Neural Plast. 2016, 8256196.","DOI":"10.1155\/2016\/8256196"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_007_w2aab3b7c33b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Aseervatham, G.S., Sivasudha, T., Jeyadevi, R., and Arul Ananth, D. (2013). Environmental factors and unhealthy lifestyle influence oxidative stress in humans \u2013 an overview. Environ. Sci. Poll. Res. Intern. 20, 4356\u20134369.","DOI":"10.1007\/s11356-013-1748-0"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_008_w2aab3b7c33b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Ashraf, G.M., Chibber, S., Mohammad, Zaidi, S.K., Tabrez, S., Ahmad, A., Shakil, S., Mushtaq, G., Baeesa, S.S., and Kamal, M.A. (2016). Recent updates on the association between alzheimer\u2019s disease and vascular dementia. Med. Chem. 12, 226\u2013237.","DOI":"10.2174\/1573406411666151030111820"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_009_w2aab3b7c33b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Auscher, C., Amory, N., van der Kemp, P., and Delbarre, F. (1979). Xanthine oxidase activity in human intestines. Histochemical and radiochemical study. Adv. Exp. Med. Biol. 122b, 197\u2013201.","DOI":"10.1007\/978-1-4684-8559-2_33"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_010_w2aab3b7c33b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Aviram, M., Rosenblat, M., Bisgaier, C.L., Newton, R.S., Primo-Parmo, S.L. and La Du, B.N. (1998). Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101, 1581.","DOI":"10.1172\/JCI1649"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_011_w2aab3b7c33b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Ayala-Pena, S. (2013). Role of oxidative DNA damage in mitochondrial dysfunction and Huntington\u2019s disease pathogenesis. Free Radic. Biol. Med. 62, 102\u2013110.","DOI":"10.1016\/j.freeradbiomed.2013.04.017"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_012_w2aab3b7c33b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Ballaz, S., Morales, I., Rodr\u00edguez, M., and Obeso, J.A. (2013). Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons. J. Neurosci. Res. 91, 1609\u20131617.","DOI":"10.1002\/jnr.23276"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_013_w2aab3b7c33b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Barber, S.C., Mead, R.J., and Shaw, P.J. (2006). Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim. Biophys. Acta Mol. Basis Dis. 1762, 1051\u20131067.","DOI":"10.1016\/j.bbadis.2006.03.008"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_014_w2aab3b7c33b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Barrantes, F.J., Borroni, V., and Vall\u00e9s, S. (2010).Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer\u2019s disease. FEBS Lett. 584, 856\u2013863.","DOI":"10.1016\/j.febslet.2009.11.036"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_015_w2aab3b7c33b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Berk, M., Dean, O.M., Cotton, S.M., Jeavons, S., Tanious, M., Kohlmann, K., Hewitt, K., Moss, K., Allwang, C., and Schapkaitz, I. (2014). The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial. J. Clin. Psych. 75, 628\u2013636.","DOI":"10.4088\/JCP.13m08454"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_016_w2aab3b7c33b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Bhattacharya, A., Bokov, A., Muller, F.L., Jernigan, A.L., Maslin, K., Diaz, V., Richardson, A., and Van Remmen, H. (2012). Dietary restriction but not rapamycin extends disease onset and survival of the H46R\/H48Q mouse model of ALS. Neurobiol. Aging 33, 1829\u20131832.","DOI":"10.1016\/j.neurobiolaging.2011.06.002"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_017_w2aab3b7c33b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Bindoff, L., Birch-Machin, M., Cartlidge, N., Parker, W., and Turnbull, D. (1989). Mitochondrial function in Parkinson\u2018s disease. Lancet 334, 49.","DOI":"10.1016\/S0140-6736(89)90291-2"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_018_w2aab3b7c33b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Biskup, S., Gerlach, M., Kupsch, A., Reichmann, H., Riederer, P., Vieregge, P., W\u00fcllner, U., and Gasser, T. (2008). Genes associated with Parkinson syndrome. J. Neurol. 255, 8\u201317.","DOI":"10.1007\/s00415-008-5005-2"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_019_w2aab3b7c33b1b6b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"Boill\u00e9e, S., Vande Velde, C., and Cleveland, D.W. (2006). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 52, 39\u201359.","DOI":"10.1016\/j.neuron.2006.09.018"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_020_w2aab3b7c33b1b6b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Bourin, M., Ripoll, N., and Dailly, E. (2003). Nicotinic receptors and Alzheimer\u2019s disease. Curr. Med. Res. Opin. 19, 169\u2013177.","DOI":"10.1185\/030079903125001631"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_021_w2aab3b7c33b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Braak, H., Del Tredici, K., R\u00fcb, U., de Vos, R.A., Steur, E.N.J., and Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211.","DOI":"10.1016\/S0197-4580(02)00065-9"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_022_w2aab3b7c33b1b6b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Browne, S.E. and Beal, M.F. (2006). Oxidative damage in Huntington\u2019s disease pathogenesis. Antioxd. Redox Signal. 8, 2061\u20132073.","DOI":"10.1089\/ars.2006.8.2061"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_023_w2aab3b7c33b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Browne, S.E., Ferrante, R.J., and Beal, M.F. (1999). Oxidative stress in Huntington\u2019s disease. Brain Pathol. 9, 147\u2013163.","DOI":"10.1111\/j.1750-3639.1999.tb00216.x"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_024_w2aab3b7c33b1b6b1ab2b1c24Aa","unstructured":"Butzlaff, M. and Ponimaskin, E. (2016). The role of serotonin receptors in Alzheimer\u2019s disease. Opera. Med. Physiol. 2, 77\u201386."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_025_w2aab3b7c33b1b6b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Carrard, G., Bulteau, A.L., Petropoulos, I., and Friguet, B. (2002). Impairment of proteasome structure and function in aging. Int. J. Biochem. Cell Bio. 34, 1461\u20131474.","DOI":"10.1016\/S1357-2725(02)00085-7"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_026_w2aab3b7c33b1b6b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"Chu, D.C.M., Penney, J.B., and Young, A.B. (1987). Cortical GABA-B and GABA-A receptors in Alzheimer\u2019s disease: a quantitative autoradiographic study. Neurology, 37, 1454.","DOI":"10.1212\/WNL.37.9.1454"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_027_w2aab3b7c33b1b6b1ab2b1c27Aa","doi-asserted-by":"crossref","unstructured":"Chuang, Y.C., Chang, A.Y.W., Lin, J.W., Hsu, S.P., and Chan, S.H.H. (2004). Mitochondrial dysfunction and ultrastructural damage in the hippocampus during kainic acid-induced status epilepticus in the rat. Epilepsia 45, 1202\u20131209.","DOI":"10.1111\/j.0013-9580.2004.18204.x"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_028_w2aab3b7c33b1b6b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"Chuang, Y., Chen, S., Lin, T., Liou, C., Chang, W., Chan, S., and Chang, A. (2007). Upregulation of nitric oxide synthase II contributes to apoptotic cell death in the hippocampal CA3 subfield via a cytochrome c\/caspase-3 signaling cascade following induction of experimental temporal lobe status epilepticus in the rat. Neuropharmacology 52, 1263\u20131273.","DOI":"10.1016\/j.neuropharm.2007.01.010"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_029_w2aab3b7c33b1b6b1ab2b1c29Aa","unstructured":"Clarke, D. and Sokoloff, L. (1999). Circulation and energy metabolism of the brain. (Philadelphia, USA: Lippincott-Raven)."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_030_w2aab3b7c33b1b6b1ab2b1c30Aa","doi-asserted-by":"crossref","unstructured":"Cock, H.R. (2002). The role of mitochondria and oxidative stress in neuronal damage after brief and prolonged seizures. Prog. Brain Res. 135, 187\u2013196.","DOI":"10.1016\/S0079-6123(02)35018-0"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_031_w2aab3b7c33b1b6b1ab2b1c31Aa","doi-asserted-by":"crossref","unstructured":"Cock, H.R., Tong, X., Hargreaves, I.P., Heales, S.J.R., Clark, J.B., Patsalos, P.N., Thom, M., Groves, M., Schapira, A.H.V., and Shorvon, S.D. (2002). Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat. Epilepsy. Res. 48, 157\u2013168.","DOI":"10.1016\/S0920-1211(01)00334-5"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_032_w2aab3b7c33b1b6b1ab2b1c32Aa","doi-asserted-by":"crossref","unstructured":"Cutler, R.G. and Rodrigues, H. (Ed.). (2002). Critical Reviews of Oxidative Stress and Ageing: Advances in Basic Science, Diagnostics and Intervention. ISBN: 978-981-4490-94-8 (ebook), World Scientific Publishing Company. UK.","DOI":"10.1142\/9789812775733"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_033_w2aab3b7c33b1b6b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"Danial, N.N. and Korsmeyer, S.J. (2004). Cell death: critical control points. Cell 116, 205\u2013219.","DOI":"10.1016\/S0092-8674(04)00046-7"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_034_w2aab3b7c33b1b6b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"de Sousa, R.T., Zarate, C.A., Zanetti, M.V., Costa, A.C., Talib, L.L., Gattaz, W.F., and Machado-Vieira, R. (2014). Oxidative stress in early stage bipolar disorder and the association with response to lithium. J. Psych. Res. 50, 36\u201341.","DOI":"10.1016\/j.jpsychires.2013.11.011"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_035_w2aab3b7c33b1b6b1ab2b1c35Aa","doi-asserted-by":"crossref","unstructured":"DiFiglia, M. (1990). Excitotoxic injury of the neostriatum: a model for Huntington\u2019s disease. Trends Neurosci. 13, 286\u2013289.","DOI":"10.1016\/0166-2236(90)90111-M"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_036_w2aab3b7c33b1b6b1ab2b1c36Aa","doi-asserted-by":"crossref","unstructured":"Droge, W. (2002). Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47\u201395.","DOI":"10.1152\/physrev.00018.2001"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_037_w2aab3b7c33b1b6b1ab2b1c37Aa","doi-asserted-by":"crossref","unstructured":"Duyckaerts, C., Delatour, B., and Potier, M.-C. (2009). Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 118, 5\u201336.","DOI":"10.1007\/s00401-009-0532-1"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_038_w2aab3b7c33b1b6b1ab2b1c38Aa","doi-asserted-by":"crossref","unstructured":"Eghiaian, F., Grosclaude, J., Lesceu, S., Debey, P., Doublet, B., Tr\u00e9guer, E., Rezaei, H., and Knossow, M. (2004). Insight into the PrP(C) \u2192 PrP(Sc) conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants. Proc. Natl. Acad. Sci. USA 101, 10254\u201310259.","DOI":"10.1073\/pnas.0400014101"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_039_w2aab3b7c33b1b6b1ab2b1c39Aa","doi-asserted-by":"crossref","unstructured":"Emerit, J., Edeas, M., and Bricaire, F. (2004). Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58, 39\u201346.","DOI":"10.1016\/j.biopha.2003.11.004"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_040_w2aab3b7c33b1b6b1ab2b1c40Aa","unstructured":"Engel, T. and Henshall, D.C. (2009). Apoptosis, Bcl-2 family proteins, and caspases: the ABCs of seizure-damage and epileptogenesis. Int. J. Physiol. Pathophysiol. Pharmacol. 1, 97\u2013115."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_041_w2aab3b7c33b1b6b1ab2b1c41Aa","doi-asserted-by":"crossref","unstructured":"Folbergrov\u00e1, J. and Kunz, W.S. (2012). Mitochondrial dysfunction in epilepsy. Mitochondrion. 12, 35\u201340.","DOI":"10.1016\/j.mito.2011.04.004"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_042_w2aab3b7c33b1b6b1ab2b1c42Aa","doi-asserted-by":"crossref","unstructured":"Gawryluk, J.W., Wang, J.-F., Andreazza, A.C., Shao, L., and Young, L.T. (2011). Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int. J. Neuropsychopharmacol. 14, 123\u2013130.","DOI":"10.1017\/S1461145710000805"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_043_w2aab3b7c33b1b6b1ab2b1c43Aa","doi-asserted-by":"crossref","unstructured":"Gharekhani, A., Khatami, M.-R., Dashti-Khavidaki, S., Razeghi, E., Noorbala, A.-A., Hashemi-Nazari, S.-S., and Mansournia, M.-A. (2014). The effect of \u03c9-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial. Eur. J. Clin. Pharmacol. 70, 655\u2013665.","DOI":"10.1007\/s00228-014-1666-1"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_044_w2aab3b7c33b1b6b1ab2b1c44Aa","doi-asserted-by":"crossref","unstructured":"Gibson, A. and Lilley, E. (1997). Superoxide anions, free-radical scavengers, and nitrergic neurotransmission. General Pharmacol. 28, 489\u2013493.","DOI":"10.1016\/S0306-3623(96)00281-9"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_045_w2aab3b7c33b1b6b1ab2b1c45Aa","doi-asserted-by":"crossref","unstructured":"Gil-Mohapel, J., Brocardo, P.S., and Christie, B.R. (2014). The role of oxidative stress in Huntington\u2019s disease: are antioxidants good therapeutic candidates? Curr. Drug Targ. 15, 454\u2013468.","DOI":"10.2174\/1389450115666140115113734"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_046_w2aab3b7c33b1b6b1ab2b1c46Aa","doi-asserted-by":"crossref","unstructured":"Girgin, S.F., Sozmen, E.Y., Ersoz, B., and Mentes, G. (2004). Link between monoamine oxidase and nitric oxide. NeuroToxicol. 25, 91\u201399.","DOI":"10.1016\/S0161-813X(03)00089-5"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_047_w2aab3b7c33b1b6b1ab2b1c47Aa","doi-asserted-by":"crossref","unstructured":"Glajch, K.E. and Sadri-Vakili, G. (2015). Epigenetic mechanisms involved in Huntington\u2019s disease pathogenesis. J. Huntington\u2019s Dis. 4, 1\u201315.","DOI":"10.3233\/JHD-140134"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_048_w2aab3b7c33b1b6b1ab2b1c48Aa","doi-asserted-by":"crossref","unstructured":"Goehler, H., Lalowski, M., Stelzl, U., Waelter, S., Stroedicke, M., Worm, U., Droege, A., Lindenberg, K.S., Knoblichm M., Haenig, C., et al. (2004). A protein interaction network links GIT1, an enhancer of Huntingtin aggregation, to Huntington\u2019s disease. Mol. Cell 15, 853\u2013865.","DOI":"10.1016\/j.molcel.2004.09.016"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_049_w2aab3b7c33b1b6b1ab2b1c49Aa","doi-asserted-by":"crossref","unstructured":"Gomez-Pinilla, F. and Nguyen, T.T. (2012). Natural mood foods: the actions of polyphenols against psychiatric and cognitive disorders. Nutri. Neurosci. 15, 127\u2013133.","DOI":"10.1179\/1476830511Y.0000000035"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_050_w2aab3b7c33b1b6b1ab2b1c50Aa","doi-asserted-by":"crossref","unstructured":"Granger, D.N. and Kvietys, P.R. (2015). Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol. 6, 524\u2013551.","DOI":"10.1016\/j.redox.2015.08.020"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_051_w2aab3b7c33b1b6b1ab2b1c51Aa","unstructured":"Guo, C., Sun, L., Chen, X., and Zhang, D. (2013). Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen. Res. 8, 2003\u20132014."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_052_w2aab3b7c33b1b6b1ab2b1c52Aa","doi-asserted-by":"crossref","unstructured":"Halliwell B. (1998). Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Problems, resolutions, and preliminary results from nutritional supplementation studies. Free Radic. Res. 29, 469\u2013486.","DOI":"10.1080\/10715769800300531"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_053_w2aab3b7c33b1b6b1ab2b1c53Aa","doi-asserted-by":"crossref","unstructured":"Halliwell, B. (2015). Free Radicals and Other Reactive Species in Disease. (NY, USA: John Wiley & Sons), eLS. DOI: 10.1038\/npg.els.0003913.","DOI":"10.1002\/9780470015902.a0002269.pub3"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_054_w2aab3b7c33b1b6b1ab2b1c54Aa","unstructured":"Halliwell, B. and Gutteridge, J.M.C. (1999). Free Radicals in Biology and Medicine, Vol 135 (Oxford, UK: Oxford University Press)."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_055_w2aab3b7c33b1b6b1ab2b1c55Aa","doi-asserted-by":"crossref","unstructured":"Henchcliffe, C. and Beal, M.F. (2008). Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Practice Neurol. 4, 600\u2013609.","DOI":"10.1038\/ncpneuro0924"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_056_w2aab3b7c33b1b6b1ab2b1c56Aa","doi-asserted-by":"crossref","unstructured":"Hengartner, M.O. (2000). The biochemistry of apoptosis. Nature 407, 770\u2013776.","DOI":"10.1038\/35037710"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_057_w2aab3b7c33b1b6b1ab2b1c57Aa","doi-asserted-by":"crossref","unstructured":"Henshall, D.C. and Engel, T. (2013). Contribution of apoptosis-associated signaling pathways to epileptogenesis: lessons from Bcl-2 family knockouts. Neuronal mechanisms of epileptogenesis. Front Cell. Neurosci. 7, 110.","DOI":"10.3389\/fncel.2013.00110"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_058_w2aab3b7c33b1b6b1ab2b1c58Aa","doi-asserted-by":"crossref","unstructured":"Herken, H., Akyol, O., Yilmaz, H.R., Tutkun, H., Savas, H.A., Ozen, M.E., Kalenderoglu, A., and Gulec, M. (2006). Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment. Hum. Psychopharmacol. Clin. Exp. 21, 53\u201359.","DOI":"10.1002\/hup.742"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_059_w2aab3b7c33b1b6b1ab2b1c59Aa","doi-asserted-by":"crossref","unstructured":"Hersch, S., Gevorkian, S., Marder, K., Moskowitz, C., Feigin, A., Cox, M., Como, P., Zimmerman, C., Lin, M., and Zhang, L. (2006). Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2032 dG. Neurology 66, 250\u2013252.","DOI":"10.1212\/01.wnl.0000194318.74946.b6"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_060_w2aab3b7c33b1b6b1ab2b1c60Aa","doi-asserted-by":"crossref","unstructured":"Hirsch, E.C., Jenner, P., and Przedborski, S. (2013). Pathogenesis of Parkinson\u2019s disease. Move Disord. 28, 24\u201330.","DOI":"10.1002\/mds.25032"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_061_w2aab3b7c33b1b6b1ab2b1c61Aa","doi-asserted-by":"crossref","unstructured":"Hui, J., Zhang, Z.J., Zhang, X., Shen, Y., and Gao, Y.J. (2013). Repetitive hyperbaric oxygen treatment attenuates complete Freund\u2019s adjuvant-induced pain and reduces glia-mediated neuroinflammation in the spinal cord. J. Pain 14, 747\u2013758.","DOI":"10.1016\/j.jpain.2013.02.003"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_062_w2aab3b7c33b1b6b1ab2b1c62Aa","doi-asserted-by":"crossref","unstructured":"Hwang, O. (2013). Role of oxidative stress in Parkinson\u2019s disease. Exp. Neurobiol. 22, 11\u201317.","DOI":"10.5607\/en.2013.22.1.11"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_063_w2aab3b7c33b1b6b1ab2b1c63Aa","doi-asserted-by":"crossref","unstructured":"Ide, K., Yamada, H., Umegaki, K., Mizuno, K., Kawakami, N., Hagiwara, Y., Matsumoto, M., Yoshida, H., Kim, K., and Shiosaki, E. (2015). Lymphocyte vitamin C levels as potential biomarker for progression of Parkinson\u2019s disease. Nutrition 31, 406\u2013408.","DOI":"10.1016\/j.nut.2014.08.001"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_064_w2aab3b7c33b1b6b1ab2b1c64Aa","doi-asserted-by":"crossref","unstructured":"Islam, B.U. and Tabrez, S. (2017). Management of Alzheimer\u2019s disease-an insight of the enzymatic and other novel potential targets. Int. J. Biol. Macromol. 97, 700\u2013709.","DOI":"10.1016\/j.ijbiomac.2017.01.076"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_065_w2aab3b7c33b1b6b1ab2b1c65Aa","doi-asserted-by":"crossref","unstructured":"Islam, B.U., Khan, M.S., Jabir, N.R., Kamal, M.A., and Tabrez. S. (2017a). Elucidating treatment of Alzheimer\u2019s disease via different receptors. Curr. Top Med. Chem. 17, 1400\u20131407.","DOI":"10.2174\/1568026617666170103163715"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_066_w2aab3b7c33b1b6b1ab2b1c66Aa","doi-asserted-by":"crossref","unstructured":"Islam, B.U., Zaidi, S.K., Kamal, M.A., and Tabrez, S. (2017b). Exploration of various proteins for the treatment of Alzheimer\u2019s disease. Curr. Drug Metab. 18, 808\u2013813. doi: 10.2174\/1389200218666170203110135.","DOI":"10.2174\/1389200218666170203110135"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_067_w2aab3b7c33b1b6b1ab2b1c67Aa","doi-asserted-by":"crossref","unstructured":"Jabir, N.R., Kamal, M.A., Abuzenadah, A.M., Gan, S.H., Alama, M.N., Baeesa, S.S., and Tabrez, S. (2014). Alzheimer\u2019s and type 2 diabetes treatment via common enzyme targeting. CNS Neurol. Disord. Drug Targets 13, 299\u2013304.","DOI":"10.2174\/18715273113126660145"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_068_w2aab3b7c33b1b6b1ab2b1c68Aa","doi-asserted-by":"crossref","unstructured":"Jabir, N.R., Firoz, C.K., Baeesa, S.S., Ashraf, G.M., Akhtar, S., Kamal, W., Kamal, M.A., and Tabrez, S. (2015). Synopsis on the linkage of Alzheimer\u2019s and Parkinson\u2019s disease with chronic diseases. CNS Neurosci. Ther. 21, 1\u20137.","DOI":"10.1111\/cns.12344"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_069_w2aab3b7c33b1b6b1ab2b1c69Aa","doi-asserted-by":"crossref","unstructured":"Jin, H., Kanthasamy, A., Ghosh, A., Anantharam, V., Kalyanaraman, B., and Kanthasamy, A.G. (2014). Mitochondria-targeted antioxidants for treatment of Parkinson\u2019s disease: preclinical and clinical outcomes. Biochim. Biophys. Acta 1842, 1282\u20131294.","DOI":"10.1016\/j.bbadis.2013.09.007"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_070_w2aab3b7c33b1b6b1ab2b1c70Aa","unstructured":"Jin, J.L., Fang, M., Zhao, Y.-X., and Liu, X.-Y. (2015). Roles of sigma-1 receptors in Alzheimer\u2019s disease. Int. J. Clin. Exp. Med. 8, 4808\u20134820."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_071_w2aab3b7c33b1b6b1ab2b1c71Aa","doi-asserted-by":"crossref","unstructured":"Jomova, K., Vondrakova, D., Lawson, M., and Valko, M. (2010). Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 345, 91\u2013104.","DOI":"10.1007\/s11010-010-0563-x"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_072_w2aab3b7c33b1b6b1ab2b1c72Aa","doi-asserted-by":"crossref","unstructured":"Jucker, M. and Walker, L.C. (2011). Pathogenic protein seeding in Alzheimer\u2019s disease and other neurodegenerative disorders. Ann. Neurol. 70, 532\u2013540.","DOI":"10.1002\/ana.22615"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_073_w2aab3b7c33b1b6b1ab2b1c73Aa","unstructured":"Kajta, M.G. (2004). Apoptosis in the central nervous system: mechanisms and protective strategies. Pol. J. Pharmacol. 56, 689\u2013700."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_074_w2aab3b7c33b1b6b1ab2b1c74Aa","doi-asserted-by":"crossref","unstructured":"Kamal, M.A., Priyamvada, S., Anbazhagan, A.N., Jabir, N.R., Tabrez, S., and Greig, N.H. (2014). Linking Alzheimer\u2019s disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation. CNS Neurol. Disord. Drug Targets 13, 338\u2013346.","DOI":"10.2174\/18715273113126660137"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_075_w2aab3b7c33b1b6b1ab2b1c75Aa","doi-asserted-by":"crossref","unstructured":"Keller, J.N., Huang, F.F., and Markesbery, W.R. (2000). Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neurosci. 98, 149\u2013156.","DOI":"10.1016\/S0306-4522(00)00067-1"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_076_w2aab3b7c33b1b6b1ab2b1c76Aa","doi-asserted-by":"crossref","unstructured":"Kennedy, T.P., Rao, N.V., Hopkins, C., Pennington, L., Tolley, E., and Hoidal, J.R. (1989). Role of reactive oxygen species in reperfusion injury of the rabbit lung. J. Clin. Invest. 83, 1326\u20131335.","DOI":"10.1172\/JCI114019"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_077_w2aab3b7c33b1b6b1ab2b1c77Aa","doi-asserted-by":"crossref","unstructured":"Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E., and Wang, P.S. (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J. Am. Med. Assoc. 289, 3095\u20133105.","DOI":"10.1001\/jama.289.23.3095"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_078_w2aab3b7c33b1b6b1ab2b1c78Aa","unstructured":"Khan, R.A. and Rai, V. (2016). Towards Understanding Epileptic Seizures in the Human Brain: A Computational Approach to Origins. International Conference: Excitatory-Inhibitory Signaling Balance as Therapeutic Target in Epilepsy. August 26\u201327. Montreal, Canada."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_079_w2aab3b7c33b1b6b1ab2b1c79Aa","doi-asserted-by":"crossref","unstructured":"Khan, M.S., Tabrez, S., Priyadarshini, M., Priyamvada, S., and Khan, M.M. (2012). Targeting Parkinson\u2019s \u2013 tyrosine hydroxylase and oxidative stress as points of interventions. CNS Neurol. Disord. Drug Targets 11, 368\u2013380.","DOI":"10.2174\/187152712800792848"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_080_w2aab3b7c33b1b6b1ab2b1c80Aa","doi-asserted-by":"crossref","unstructured":"Khanzode, S.D., Dakhale, G.N., Khanzode, S.S., Saoji, A., and Palasodkar, R. (2003). Oxidative damage and major depression: the potential antioxidant action of selective serotonin reuptake inhibitors. Redox Rep. 8, 365\u2013370.","DOI":"10.1179\/135100003225003393"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_081_w2aab3b7c33b1b6b1ab2b1c81Aa","doi-asserted-by":"crossref","unstructured":"Kihara, T. and Shimohama, S. (2004). Alzheimer\u2019s disease and acetylcholine receptors. Acta Neurobiol. Exp. (Warsaw) 64, 99\u2013105.","DOI":"10.55782\/ane-2004-1495"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_082_w2aab3b7c33b1b6b1ab2b1c82Aa","doi-asserted-by":"crossref","unstructured":"Kodydkov\u00e1, J., V\u00e1vrov\u00e1, L., Zeman, M., Jir\u00e1k, R., Mac\u00e1\u0161ek, J., Sta\u0148kov\u00e1, B., Tvrzick\u00e1, E., and \u017d\u00e1k, A. (2009). Antioxidative enzymes and increased oxidative stress in depressive women. Clin. Biochem. 42, 1368\u20131374.","DOI":"10.1016\/j.clinbiochem.2009.06.006"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_083_w2aab3b7c33b1b6b1ab2b1c83Aa","doi-asserted-by":"crossref","unstructured":"Kong, Q. and Lin, C.-l.G. (2010). Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell. Mol. Life Sci. 67, 1817\u20131829.","DOI":"10.1007\/s00018-010-0277-y"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_084_w2aab3b7c33b1b6b1ab2b1c84Aa","doi-asserted-by":"crossref","unstructured":"Kraytsberg, Y., Kudryavtseva, E., McKee, A.C., Geula, C., Kowall, N.W., and Khrapko, K. (2006). Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 38, 518\u2013520.","DOI":"10.1038\/ng1778"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_085_w2aab3b7c33b1b6b1ab2b1c85Aa","doi-asserted-by":"crossref","unstructured":"Kudin, A.P., Kudina, T.A., Seyfried, J., Vielhaber, S., Beck, H., Elger, C.E., and Kunz, W.S. (2002). Seizure-dependent modulation of mitochondrial oxidative phosphorylation in rat hippocampus. Eur. J. Neurosci. 15, 1105\u20131114.","DOI":"10.1046\/j.1460-9568.2002.01947.x"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_086_w2aab3b7c33b1b6b1ab2b1c86Aa","doi-asserted-by":"crossref","unstructured":"Kunz, T. and Oliw, E.H. (2001). Nimesulide aggravates kainic acid-induced seizures in the rat. Pharmacol. Toxicol. 88, 271\u2013276.","DOI":"10.1111\/j.1600-0773.2001.880509.x"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_087_w2aab3b7c33b1b6b1ab2b1c87Aa","doi-asserted-by":"crossref","unstructured":"LaFerla, F.M. and Oddo, S. (2005). Alzheimer\u2019s disease: a beta, tau, and synaptic dysfunction. Trends Mol. Med. 11, 170\u2013176.","DOI":"10.1016\/j.molmed.2005.02.009"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_088_w2aab3b7c33b1b6b1ab2b1c88Aa","doi-asserted-by":"crossref","unstructured":"Lavrik, I.N., Golks, A., and Krammer, P.H. (2005). Caspases: pharmacological manipulation of cell death. J. Clin. Invest. 115, 2665\u20132672.","DOI":"10.1172\/JCI26252"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_089_w2aab3b7c33b1b6b1ab2b1c89Aa","doi-asserted-by":"crossref","unstructured":"Lee, Y.M., Kang, H.C., Lee, J.S., Kim, S.H., Kim, E.Y., Lee, S.K., Slama, A., and Kim, H.D. (2008). Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions. Epilepsia 49, 685\u2013690.","DOI":"10.1111\/j.1528-1167.2007.01522.x"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_090_w2aab3b7c33b1b6b1ab2b1c90Aa","doi-asserted-by":"crossref","unstructured":"Leonard, B. and Maes, M. (2012). Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev. 36, 764\u2013785.","DOI":"10.1016\/j.neubiorev.2011.12.005"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_091_w2aab3b7c33b1b6b1ab2b1c91Aa","doi-asserted-by":"crossref","unstructured":"Liang, L.-P. and Patel, M. (2004). Mitochondrial oxidative stress and increased seizure susceptibility in SOD2 mice. Free Radic. Biol. Med. 36, 542\u2013554.","DOI":"10.1016\/j.freeradbiomed.2003.11.029"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_092_w2aab3b7c33b1b6b1ab2b1c92Aa","doi-asserted-by":"crossref","unstructured":"Liang, L.-P. and Patel, M. (2006). Seizure-induced changes in mitochondrial redox status. Free Radic. Biol. Med. 40, 316\u2013322.","DOI":"10.1016\/j.freeradbiomed.2005.08.026"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_093_w2aab3b7c33b1b6b1ab2b1c93Aa","doi-asserted-by":"crossref","unstructured":"Liang, L., Ho, Y., and Patel, M. (2000). Mitochondrial superoxide production in kainate-induced hippocampal damage. Neurosci. 101, 563\u2013570.","DOI":"10.1016\/S0306-4522(00)00397-3"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_094_w2aab3b7c33b1b6b1ab2b1c94Aa","doi-asserted-by":"crossref","unstructured":"Lin, M.T. and Beal, M.F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787\u2013795.","DOI":"10.1038\/nature05292"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_095_w2aab3b7c33b1b6b1ab2b1c95Aa","doi-asserted-by":"crossref","unstructured":"Ling, J. and S\u00f6ll, D. (2010). Severe oxidative stress induces protein mistranslation through impairment of an aminoacyl-tRNA synthetase editing site. Proc. Natl. Acad. Sci. USA 107, 4028\u20134033.","DOI":"10.1073\/pnas.1000315107"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_096_w2aab3b7c33b1b6b1ab2b1c96Aa","doi-asserted-by":"crossref","unstructured":"Liu, W., Acin-Perez, R., Geghman, K.D., Manfredi, G., Lu, B., and Li, C. (2011). Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc. Natl. Acad. Sci. USA 108, 12920\u201312924.","DOI":"10.1073\/pnas.1107332108"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_097_w2aab3b7c33b1b6b1ab2b1c97Aa","doi-asserted-by":"crossref","unstructured":"Lobo, V., Patil, A., Phatak, A., and Chandra, N. (2010). Free radicals, antioxidants, and functional foods: impact on human health. Pharmacog. Rev. 4, 118\u2013126.","DOI":"10.4103\/0973-7847.70902"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_098_w2aab3b7c33b1b6b1ab2b1c98Aa","doi-asserted-by":"crossref","unstructured":"Lovell, M.A., Robertson, J.D., Teesdale, W.J., Campbell, J.L., and Markesbery, W.R. (1998). Copper, iron, and zinc in Alzheimer\u2019s disease senile plaques. J. Neurol. Sci. 158, 47\u201352.","DOI":"10.1016\/S0022-510X(98)00092-6"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_099_w2aab3b7c33b1b6b1ab2b1c99Aa","doi-asserted-by":"crossref","unstructured":"Maehara, Y., Egashira, A., Oki, E., Kakeji, Y., and Tsuzuki, T. (2008). DNA repair dysfunction in gastrointestinal tract cancers. Cancer Sci. 99, 451\u2013458.","DOI":"10.1111\/j.1349-7006.2007.00671.x"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_100_w2aab3b7c33b1b6b1ab2b1d100Aa","unstructured":"Maes, M., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., and Bosmans, E. (2010). Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis\/chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression. Neurol. Endocrinol. Lett. 32, 133\u2013140."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_101_w2aab3b7c33b1b6b1ab2b1d101Aa","doi-asserted-by":"crossref","unstructured":"Malonek, D. and Grinvald, A. (1996). Interactions between electrical activity and cortical microcirculation revealed by imaging spectroscopy: implications for functional brain mapping. Science 272, 551.","DOI":"10.1126\/science.272.5261.551"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_102_w2aab3b7c33b1b6b1ab2b1d102Aa","doi-asserted-by":"crossref","unstructured":"Martindale, J.L. and Holbrook, N.J. (2002). Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol 192, 1\u201315.","DOI":"10.1002\/jcp.10119"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_103_w2aab3b7c33b1b6b1ab2b1d103Aa","doi-asserted-by":"crossref","unstructured":"Mattiazzi, M., D\u2019Aurelio, M., Gajewski, C.D., Martushova, K., Kiaei, M., Beal, M.F., and Manfredi, G. (2002). Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 277, 29626\u201329633.","DOI":"10.1074\/jbc.M203065200"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_104_w2aab3b7c33b1b6b1ab2b1d104Aa","doi-asserted-by":"crossref","unstructured":"Mecocci, P., MacGarvey, U., Kaufman, A.E., Koontz, D., Shoffner, J.M., Wallace, D.C., and Beal, M.F. (1993). Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34, 609\u2013616.","DOI":"10.1002\/ana.410340416"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_105_w2aab3b7c33b1b6b1ab2b1d105Aa","doi-asserted-by":"crossref","unstructured":"Mehlum, L., Ramberg, M., T\u00f8rmoen, A.J., Haga, E., Diep, L.M., Stanley, B.H., Miller, A.L., Sund, A.M., and Gr\u00f8holt, B. (2016). Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. J. Am. Acad. Child Adolesc. Psychiatry. 55, 295\u2013300.","DOI":"10.1016\/j.jaac.2016.01.005"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_106_w2aab3b7c33b1b6b1ab2b1d106Aa","doi-asserted-by":"crossref","unstructured":"Melov, S., Schneider, J.A., Day, B.J., Hinerfeld, D., Coskun, P., Mirra, S.S., Crapo, J.D., and Wallace, D.C. (1998). A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 18, 159\u2013163.","DOI":"10.1038\/ng0298-159"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_107_w2aab3b7c33b1b6b1ab2b1d107Aa","unstructured":"Merzbacher, E. (1998). Quantum Mechanics, 3rd Ed. (NY, USA: John Wiley Inc.), ISBN-10: 0471887021."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_108_w2aab3b7c33b1b6b1ab2b1d108Aa","doi-asserted-by":"crossref","unstructured":"Michel, T.M., Pulschen, D., and Thome, J. (2012). The role of oxidative stress in depressive disorders. Curr. Pharm. Des. 18, 5890\u20135899.","DOI":"10.2174\/138161212803523554"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_109_w2aab3b7c33b1b6b1ab2b1d109Aa","doi-asserted-by":"crossref","unstructured":"Milder, J. and Patel, M. (2012). Modulation of oxidative stress and mitochondrial function by the ketogenic diet. Epilepsy Res. 100, 295\u2013303.","DOI":"10.1016\/j.eplepsyres.2011.09.021"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_110_w2aab3b7c33b1b6b1ab2b1d110Aa","doi-asserted-by":"crossref","unstructured":"Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T., and Kagawa, Y. (1989). Deficiencies in complex I subunits of the respiratory chain in Parkinson\u2019s disease. Biochem. Biophys. Res. Commun. 163, 1450\u20131455.","DOI":"10.1016\/0006-291X(89)91141-8"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_111_w2aab3b7c33b1b6b1ab2b1d111Aa","unstructured":"Montine, T.J., Amarnath, V., Martin, M.E., Strittmatter, W.J., and Graham, D.G. (1996). E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 148, 89."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_112_w2aab3b7c33b1b6b1ab2b1d112Aa","doi-asserted-by":"crossref","unstructured":"Moreira, P.I., Nunomura, A., Nakamura, M., Takeda, A., Shenk, J.C., Aliev, G., Smith, M.A., and Perry, G. (2008). Nucleic acid oxidation in Alzheimer disease. Free Radic. Biol. Med. 44, 1493\u20131505.","DOI":"10.1016\/j.freeradbiomed.2008.01.002"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_113_w2aab3b7c33b1b6b1ab2b1d113Aa","doi-asserted-by":"crossref","unstructured":"Neymotin, A., Petri, S., Calingasan, N.Y., Wille, E., Schafer, P., Stewart, C., Hensley, K., Beal, M.F., and Kiaei, M. (2009). Lenalidomide (Revlimid\u00ae) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 220, 191\u2013197.","DOI":"10.1016\/j.expneurol.2009.08.028"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_114_w2aab3b7c33b1b6b1ab2b1d114Aa","doi-asserted-by":"crossref","unstructured":"Ng, C.F., Schafer, F.Q., Buettner, G.R., and Rodgers, V.G. (2007). The rate of cellular hydrogen peroxide removal shows dependency on GSH: mathematical insight into in vivo H2O2 and GPX concentrations. Free Radic. Res. 41, 1201\u20131211.","DOI":"10.1080\/10715760701625075"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_115_w2aab3b7c33b1b6b1ab2b1d115Aa","doi-asserted-by":"crossref","unstructured":"Nunomura, A., Moreira, P.I., Takeda, A., Smith, M.A., and Perry, G. (2007). Oxidative RNA damage and neurodegeneration. Curr. Med. Chem. 14, 2968\u20132975.","DOI":"10.2174\/092986707782794078"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_116_w2aab3b7c33b1b6b1ab2b1d116Aa","doi-asserted-by":"crossref","unstructured":"Oddo, S. and LaFerla, F.M. (2006). The role of nicotinic acetylcholine receptors in Alzheimer\u2019s disease. J. Physiol. (Paris) 99, 172\u2013179.","DOI":"10.1016\/j.jphysparis.2005.12.080"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_117_w2aab3b7c33b1b6b1ab2b1d117Aa","doi-asserted-by":"crossref","unstructured":"Ogle, W.O., Speisman, R.B., and Ormerod, B.K. (2013). Potential of treating age-related depression and cognitive decline with nutraceutical approaches: a mini-review. Gerontology 59, 23\u201331.","DOI":"10.1159\/000342208"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_118_w2aab3b7c33b1b6b1ab2b1d118Aa","doi-asserted-by":"crossref","unstructured":"Oliveira, J.M. and Lightowlers, R.N. (2010). Could successful (mitochondrial) networking help prevent Huntington\u2019s disease? EMBO Mol. Med. 2, 487\u2013489.","DOI":"10.1002\/emmm.201000104"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_119_w2aab3b7c33b1b6b1ab2b1d119Aa","doi-asserted-by":"crossref","unstructured":"Orth, M. and Schapira, A. (2001). Mitochondria and degenerative disorders. Am. J. Med. Genet. 106, 27\u201336.","DOI":"10.1002\/ajmg.1425"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_120_w2aab3b7c33b1b6b1ab2b1d120Aa","doi-asserted-by":"crossref","unstructured":"Pacher, P., Beckman, J.S., and Liaudet, L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315\u2013424.","DOI":"10.1152\/physrev.00029.2006"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_121_w2aab3b7c33b1b6b1ab2b1d121Aa","doi-asserted-by":"crossref","unstructured":"Pan, L., Yoshii, Y., Otomo, A., Ogawa, H., Iwasaki, Y., Shang, H.-F., and Hadano, S. (2012). Different human copper-zinc superoxide dismutase mutants, SOD1, and SOD1 exert distinct harmful effects on gross phenotype in mice. PLoS One 7, e33409.","DOI":"10.1371\/journal.pone.0033409"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_122_w2aab3b7c33b1b6b1ab2b1d122Aa","doi-asserted-by":"crossref","unstructured":"Panickar, K.S. and Anderson, R.A. (2011). Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia. Int. J. Mol. Sci. 12, 8181\u20138207.","DOI":"10.3390\/ijms12118181"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_123_w2aab3b7c33b1b6b1ab2b1d123Aa","doi-asserted-by":"crossref","unstructured":"Patel, M. (2004). Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic. Biol. Med. 37, 1951\u20131962.","DOI":"10.1016\/j.freeradbiomed.2004.08.021"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_124_w2aab3b7c33b1b6b1ab2b1d124Aa","unstructured":"Perez, M., Valpuesta, J.M., de Garcini, E.M., Quintana, C., Arrasate, M., Carrascosa, J.L.L., Rabano, A., de Yebenes, J.G., and Avila, J. (1998). Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy. Am. J. Pathol. 152, 1531\u20131539."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_125_w2aab3b7c33b1b6b1ab2b1d125Aa","doi-asserted-by":"crossref","unstructured":"Pickrell, A.M., Pinto, M., Hida, A., and Moraes, C.T. (2011). Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson\u2019s disease. J Neurosci 31, 17649\u201317658.","DOI":"10.1523\/JNEUROSCI.4871-11.2011"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_126_w2aab3b7c33b1b6b1ab2b1d126Aa","unstructured":"Rai, V. and Khan, R.A. (2009). Epileptic Seizures: A Dynamical Systems Approach to Understand the Origin. https:\/\/www.researchgate.net\/publication\/301698292_Epileptic_Seizures_A_Dynamical_Systems_Approach_to_Understand_the_Origin. DOI: 10.13140\/RG.2.1.4620.8881."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_127_w2aab3b7c33b1b6b1ab2b1d127Aa","doi-asserted-by":"crossref","unstructured":"Ramirez, M.J. (2013). 5-HT6 receptors and Alzheimer\u2019s disease. Alzheimer\u2019s Res. Ther. 2013, 5:15.","DOI":"10.1186\/alzrt169"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_128_w2aab3b7c33b1b6b1ab2b1d128Aa","doi-asserted-by":"crossref","unstructured":"Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O\u2019Regan, J.P., Deng, H.X., et al. (1993). Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59\u201362.","DOI":"10.1038\/364362c0"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_129_w2aab3b7c33b1b6b1ab2b1d129Aa","doi-asserted-by":"crossref","unstructured":"Rosini, M., Simoni, E., Milelli, A., Minarini, A., and Melchiorre, C. (2014). Oxidative stress in Alzheimer\u2019s disease: are we connecting the dots? J. Med. Chem. 57, 2821\u20132831.","DOI":"10.1021\/jm400970m"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_130_w2aab3b7c33b1b6b1ab2b1d130Aa","doi-asserted-by":"crossref","unstructured":"Sacher, J., Rekkas, P.V., Wilson, A.A., Houle, S., Romano, L., Hamidi, J., Rusjan, P., Fan, I., Stewart, D.E., and Meyer, J.H. (2015). Relationship of monoamine oxidase-A distribution volume to postpartum depression and postpartum crying. Neuropsychopharmacol. 40, 429\u2013435.","DOI":"10.1038\/npp.2014.190"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_131_w2aab3b7c33b1b6b1ab2b1d131Aa","doi-asserted-by":"crossref","unstructured":"Santamar\u00eda, A., P\u00e9rez-Severiano, F., Rodr\u00edguez-Mart\u00ednez, E., Maldonado, P.D., Pedraza-Chaverri, J., R\u00edos, C., and Segovia, J. (2001). Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington\u2019s disease. Neurochem. Res. 26, 419\u2013424.","DOI":"10.1023\/A:1010911417383"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_132_w2aab3b7c33b1b6b1ab2b1d132Aa","doi-asserted-by":"crossref","unstructured":"Scapagnini, G., Davinelli, S., Drago, F., De Lorenzo, A., and Oriani, G. (2012). Antioxidants as antidepressants. CNS Drugs 26, 477\u2013490.","DOI":"10.2165\/11633190-000000000-00000"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_133_w2aab3b7c33b1b6b1ab2b1d133Aa","doi-asserted-by":"crossref","unstructured":"Schapira, A., Cooper, J., Dexter, D., Jenner, P., Clark, J., and Marsden, C. (1989). Mitochondrial complex I deficiency in Parkinson\u2019s disease. Lancet 333, 1269.","DOI":"10.1016\/S0140-6736(89)92366-0"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_134_w2aab3b7c33b1b6b1ab2b1d134Aa","doi-asserted-by":"crossref","unstructured":"Schmelzer, C., Lindner, I., Rimbach, G., Niklowitz, P., Menke, T., and D\u00f6ring, F. (2008). Functions of coenzyme Q10 in inflammation and gene expression. Biofactors 32, 179\u2013183.","DOI":"10.1002\/biof.5520320121"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_136_w2aab3b7c33b1b6b1ab2b1d135Aa","doi-asserted-by":"crossref","unstructured":"Shaw, P. (2005). Molecular and cellular pathways of neurodegeneration in motor neuron disease. J. Neurol. Neurosurg. Psychiatry 76, 1046\u20131057.","DOI":"10.1136\/jnnp.2004.048652"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_137_w2aab3b7c33b1b6b1ab2b1d136Aa","doi-asserted-by":"crossref","unstructured":"Shimoji, M.J., Mhyre, T.R., and Maguire-Zeiss, K.A. (2013). Microglial activation and antioxidant responses induced by the Parkinson\u2019s disease protein \u03b1-synuclein. J. Neuroimm. Pharmacol. 8, 94\u2013117.","DOI":"10.1007\/s11481-012-9401-0"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_138_w2aab3b7c33b1b6b1ab2b1d137Aa","doi-asserted-by":"crossref","unstructured":"Shin, E.J., Jeong, J.H., Chung, Y.H., Kim, W.K., Ko, K.H., Bach, J.H., Hong, J.S., Yoneda, Y., and Kim, H.C. (2011). Role of oxidative stress in epileptic seizures. Neurochem. Int. 59, 122\u2013137.","DOI":"10.1016\/j.neuint.2011.03.025"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_139_w2aab3b7c33b1b6b1ab2b1d138Aa","doi-asserted-by":"crossref","unstructured":"Shivakumar, B.R., Anandatheerthavarada, H.K., and Ravindranath, V. (1991). Free radical scavenging systems in developing rat brain. Int. J. Dev. Neurosci. 9, 181\u2013185.","DOI":"10.1016\/0736-5748(91)90010-J"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_140_w2aab3b7c33b1b6b1ab2b1d139Aa","doi-asserted-by":"crossref","unstructured":"Shoffner, J.M., Lott, M.T., Lezza, A.M., Seibel, P., Ballinger, S.W., and Wallace, D.C. (1990). Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA Lys mutation. Cell 61, 931\u2013937.","DOI":"10.1016\/0092-8674(90)90059-N"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_141_w2aab3b7c33b1b6b1ab2b1d140Aa","doi-asserted-by":"crossref","unstructured":"Siddiqui, A., Rivera-Sanchez, S., Castro Mdel, R., Acevedo-Torres, K., Rane, A., Torres-Ramos, C.A., Nicholls, D.G., Andersen, J.K. and Ayala-Torres, S. (2012). Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington\u2019s disease. Free Radic. Biol. Med. 53, 1478\u20131488.","DOI":"10.1016\/j.freeradbiomed.2012.06.008"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_142_w2aab3b7c33b1b6b1ab2b1d141Aa","doi-asserted-by":"crossref","unstructured":"Sies, H. (1997). Oxidative stress: oxidants and antioxidants. Exp. Physiol. 82, 291\u2013295.","DOI":"10.1113\/expphysiol.1997.sp004024"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_143_w2aab3b7c33b1b6b1ab2b1d142Aa","doi-asserted-by":"crossref","unstructured":"Simon, N.M., Smoller, J.W., McNamara, K.L., Maser, R.S., Zalta, A.K., Pollack, M.H., Nierenberg, A.A., Fava, M., and Wong, K.-K. (2006). Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol. Psychiatry 60, 432\u2013435.","DOI":"10.1016\/j.biopsych.2006.02.004"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_144_w2aab3b7c33b1b6b1ab2b1d143Aa","doi-asserted-by":"crossref","unstructured":"Skaper, S.D., Facci, L., and Giusti, P. (2013). Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator. Mol. Neurobiol. 48, 340\u2013352.","DOI":"10.1007\/s12035-013-8487-6"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_145_w2aab3b7c33b1b6b1ab2b1d144Aa","doi-asserted-by":"crossref","unstructured":"Smith, M.A., Taneda, S., Richey, P.L., Miyata, S., Yan, S.-D., Stern, D., Sayre, L.M., Monnier, V.M., and Perry, G. (1994). Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Nat. Acad. Sci. USA 91, 5710\u20135714.","DOI":"10.1073\/pnas.91.12.5710"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_146_w2aab3b7c33b1b6b1ab2b1d145Aa","doi-asserted-by":"crossref","unstructured":"Smith, M.A., Sayre, L.M., Monnier, V.M., and Perry, G. (1995). Radical AGEing in Alzheimer\u2019s disease. Trends Neurosci. 18, 172\u2013176.","DOI":"10.1016\/0166-2236(95)93897-7"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_147_w2aab3b7c33b1b6b1ab2b1d146Aa","doi-asserted-by":"crossref","unstructured":"Smith, M.A., Richey Harris, P.L., Sayre, L.M., Beckman, J.S., and Perry, G. (1997). Widespread peroxynitrite-mediated damage in Alzheimer\u2019s disease. J. Neurosci. 17, 2653\u20132657.","DOI":"10.1523\/JNEUROSCI.17-08-02653.1997"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_148_w2aab3b7c33b1b6b1ab2b1d147Aa","doi-asserted-by":"crossref","unstructured":"Sohal, R.S., Sohal, B.H., and Orr, W.C. (1995). Mitochondrial superoxide and hydrogen peroxide generation, protein oxidative damage, and longevity in different species of flies. Free Radic. Biol. Med. 19, 499\u2013504.","DOI":"10.1016\/0891-5849(95)00037-X"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_149_w2aab3b7c33b1b6b1ab2b1d148Aa","doi-asserted-by":"crossref","unstructured":"Sorolla, M.A., Reverter-Branchat, G., Tamarit, J., Ferrer, I., Ros, J., and Cabiscol, E. (2008). Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic. Biol. Med. 45, 667\u2013678.","DOI":"10.1016\/j.freeradbiomed.2008.05.014"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_150_w2aab3b7c33b1b6b1ab2b1d149Aa","doi-asserted-by":"crossref","unstructured":"Stefanis, L. (2012). \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb. Perspect Med. 2, a009399.","DOI":"10.1101\/cshperspect.a009399"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_151_w2aab3b7c33b1b6b1ab2b1d150Aa","doi-asserted-by":"crossref","unstructured":"Su, F., Bai, F., Zhou, H., and Zhang, Z. (2016). Microglial toll-like receptors and Alzheimer\u2019s disease. Brain Behav. Immun. 52, 187\u2013198.","DOI":"10.1016\/j.bbi.2015.10.010"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_152_w2aab3b7c33b1b6b1ab2b1d151Aa","doi-asserted-by":"crossref","unstructured":"Sudha, K., Rao, A.V., and Rao, A. (2001). Oxidative stress and antioxidants in epilepsy. Clin. Chim. Acta. 303, 19\u201324.","DOI":"10.1016\/S0009-8981(00)00337-5"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_153_w2aab3b7c33b1b6b1ab2b1d152Aa","doi-asserted-by":"crossref","unstructured":"Suraweera, A., Munch, C., Hanssum, A., and Bertolotti, A. (2012). Failure of amino acid homeostasis causes cell death following proteasome inhibition. Mol. Cell 48, 242\u2013253.","DOI":"10.1016\/j.molcel.2012.08.003"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_154_w2aab3b7c33b1b6b1ab2b1d153Aa","doi-asserted-by":"crossref","unstructured":"Tabner, B.J., El-Agnaf, O.M., German, M.J., Fullwood, N.J., and Allsop, D. (2005). Protein aggregation, metals and oxidative stress in neurodegenerative diseases. Biochem. Soc. Transac. 33, 1082\u20131086.","DOI":"10.1042\/BST0331082"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_155_w2aab3b7c33b1b6b1ab2b1d154Aa","doi-asserted-by":"crossref","unstructured":"Thompson, J.K., Peterson, M.R., and Freeman, R.D. (2003). Single-neuron activity and tissue oxygenation in the cerebral cortex. Science 299, 1070\u20131072.","DOI":"10.1126\/science.1079220"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_156_w2aab3b7c33b1b6b1ab2b1d155Aa","doi-asserted-by":"crossref","unstructured":"Trifunovic, A. and Larsson, N.G. (2008). Mitochondrial dysfunction as a cause of aging. J. Internal Med. 263, 167\u2013178.","DOI":"10.1111\/j.1365-2796.2007.01905.x"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_157_w2aab3b7c33b1b6b1ab2b1d156Aa","doi-asserted-by":"crossref","unstructured":"Tufi, R., Gandhi, S., de Castro, I.P., Lehmann, S., Angelova, P.R., Dinsdale, D., Deas, E., Plun-Favreau, H., Nicotera, P., Abramov, A.Y., et al. (2014). Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson\u2019s disease. Nat. Cell Biol. 16, 157\u2013166.","DOI":"10.1038\/ncb2901"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_158_w2aab3b7c33b1b6b1ab2b1d157Aa","doi-asserted-by":"crossref","unstructured":"Turner, C. and Schapira, A.H. (2001). Mitochondrial dysfunction in neurodegenerative disorders and aging. Adv. Exp. Med. Biol. 487, 229\u2013251.","DOI":"10.1007\/978-1-4615-1249-3_19"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_159_w2aab3b7c33b1b6b1ab2b1d158Aa","doi-asserted-by":"crossref","unstructured":"Turrens, J.F., Freeman, B.A., Levitt, J.G., and Crapo, J.D. (1982). The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch. Biochem. Biophys. 217, 401\u2013410.","DOI":"10.1016\/0003-9861(82)90518-5"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_160_w2aab3b7c33b1b6b1ab2b1d159Aa","doi-asserted-by":"crossref","unstructured":"Uttara, B., Singh, A.V., Zamboni, P., and Mahajan, R.T. (2009). Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 7, 65\u201374.","DOI":"10.2174\/157015909787602823"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_161_w2aab3b7c33b1b6b1ab2b1d160Aa","doi-asserted-by":"crossref","unstructured":"Vargas, M.R., Johnson, D.A., and Johnson, J.A. (2011). Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model. Neurobiol. Dis. 43, 543\u2013551.","DOI":"10.1016\/j.nbd.2011.04.025"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_162_w2aab3b7c33b1b6b1ab2b1d161Aa","doi-asserted-by":"crossref","unstructured":"Waldbaum, S. and Patel, M. (2010). Mitochondrial dysfunction and oxidative stress: a contributing link to acquired epilepsy? J. Bioenerget. Biomembr. 42, 449\u2013455.","DOI":"10.1007\/s10863-010-9320-9"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_163_w2aab3b7c33b1b6b1ab2b1d162Aa","doi-asserted-by":"crossref","unstructured":"Waldbaum, S., Liang, L.P., and Patel, M. (2010). Persistent impairment of mitochondrial and tissue redox status during lithium-pilocarpine-induced epileptogenesis. J. Neurochem. 115, 1172\u20131182.","DOI":"10.1111\/j.1471-4159.2010.07013.x"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_164_w2aab3b7c33b1b6b1ab2b1d163Aa","doi-asserted-by":"crossref","unstructured":"Walker, F.O. (2007). Huntington\u2019s disease. Lancet 369, 218\u2013228.","DOI":"10.1016\/S0140-6736(07)60111-1"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_165_w2aab3b7c33b1b6b1ab2b1d164Aa","doi-asserted-by":"crossref","unstructured":"Walker, L.C. and LeVine, H., 3rd. (2000). The cerebral proteopathies. Neurobiol. Aging 21, 559\u2013561.","DOI":"10.1016\/S0197-4580(00)00160-3"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_166_w2aab3b7c33b1b6b1ab2b1d165Aa","doi-asserted-by":"crossref","unstructured":"Wallace, D.C., Zheng, X., Lott, M.T., Shoffner, J.M., Hodge, J.A., Kelley, R.I., Epstein, C.M., and Hopkins, L.C. (1988). Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 55, 601\u2013610.","DOI":"10.1016\/0092-8674(88)90218-8"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_167_w2aab3b7c33b1b6b1ab2b1d166Aa","doi-asserted-by":"crossref","unstructured":"Wang, J.Q., Chen, Q., Wang, X., Wang, Q.C., Wang, Y., Cheng, H.P., Guo, C., Sun, Q., Chen, Q., and Tang, T.S. (2013). Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease. J. Biol. Chem. 288, 3070\u20133084.","DOI":"10.1074\/jbc.M112.407726"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_168_w2aab3b7c33b1b6b1ab2b1d167Aa","doi-asserted-by":"crossref","unstructured":"Wasterlain, C.G., Fujikawa, D.G., Penix, L., and Sankar, R. (1993). Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 34, S37\u2013S53.","DOI":"10.1111\/j.1528-1157.1993.tb05905.x"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_169_w2aab3b7c33b1b6b1ab2b1d168Aa","doi-asserted-by":"crossref","unstructured":"Weinreb, O., Amit, T., Bar-Am, O., and Youdim, M.B. (2016). Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron, and \u03b2-amyloid in aging and Alzheimer\u2019s disease. British J. Pharmacol. 173, 2080\u20132094.","DOI":"10.1111\/bph.13318"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_170_w2aab3b7c33b1b6b1ab2b1d169Aa","unstructured":"Wenk, G.L. (2006). Neuropathologic changes in Alzheimer\u2019s disease: potential targets for treatment. J. Clin. Psychiatry 67, 3."},{"key":"2026080509241277460_j_hsz-2017-0250_ref_171_w2aab3b7c33b1b6b1ab2b1d170Aa","doi-asserted-by":"crossref","unstructured":"Weydert, C.J. and Cullen, J.J. (2010). Measurement of superoxide dismutase, catalase, and glutathione peroxidase in cultured cells and tissue. Nat. Protoc. 5, 51\u201366.","DOI":"10.1038\/nprot.2009.197"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_172_w2aab3b7c33b1b6b1ab2b1d171Aa","doi-asserted-by":"crossref","unstructured":"Willmore, L.J., Sypert, G.W., and Munson, J.B. (1978). Recurrent seizures induced by cortical iron injection: a model of posttraumatic epilepsy. Ann. Neurol. 4, 329\u2013336.","DOI":"10.1002\/ana.410040408"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_173_w2aab3b7c33b1b6b1ab2b1d172Aa","doi-asserted-by":"crossref","unstructured":"Wolkowitz, O.M., Mellon, S.H., Epel, E.S., Lin, J., Dhabhar, F.S., Su, Y., Reus, V.I., Rosser, R., Burke, H.M., and Kupferman, E. (2011). Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress-preliminary findings. PLoS One 6, e17837.","DOI":"10.1371\/journal.pone.0017837"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_174_w2aab3b7c33b1b6b1ab2b1d173Aa","doi-asserted-by":"crossref","unstructured":"Wu, S.-B., Ma, Y.-S., Wu, Y.-T., Chen, Y.-C., and Wei, Y.-H. (2010). Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome. Mol. Neurobiol. 41, 256\u2013266.","DOI":"10.1007\/s12035-010-8123-7"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_175_w2aab3b7c33b1b6b1ab2b1d174Aa","doi-asserted-by":"crossref","unstructured":"Xiang, W., Schlachetzki, J.C., Helling, S., Bussmann, J.C., Berlinghof, M., Sch\u00e4ffer, T.E., Marcus, K., Winkler, J., Klucken, J., and Becker, C.-M. (2013). Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of \u03b1-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity. Mol. Cell. Neurosci. 54, 71\u201383.","DOI":"10.1016\/j.mcn.2013.01.004"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_176_w2aab3b7c33b1b6b1ab2b1d175Aa","doi-asserted-by":"crossref","unstructured":"Yu, B.P. (1994). Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74, 139\u2013162.","DOI":"10.1152\/physrev.1994.74.1.139"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_177_w2aab3b7c33b1b6b1ab2b1d176Aa","doi-asserted-by":"crossref","unstructured":"Yusuf, M., Khan, R.A., and Ahmed, B. (2008). Syntheses and anti-depressant activity of 5-amino-1, 3, 4-thiadiazole-2-thiol imines and thiobenzyl derivatives. Bioorg Med Chem 16, 8029\u20138034.","DOI":"10.1016\/j.bmc.2008.07.056"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_178_w2aab3b7c33b1b6b1ab2b1d177Aa","doi-asserted-by":"crossref","unstructured":"Yusuf, M., Khan, R.A., Khan, M., and Ahmed, B. (2012). Plausible antioxidant biomechanics and anticonvulsant pharmacological activity of brain-targeted \u03b2-carotene nanoparticles. Int. J. Nanomed. 7, 4311\u20134322.","DOI":"10.2147\/IJN.S34588"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_179_w2aab3b7c33b1b6b1ab2b1d178Aa","doi-asserted-by":"crossref","unstructured":"Yusuf, M., Khan, M., Khan, R.A., and Ahmed, B. (2013). Preparation, characterization, in vivo and biochemical evaluation of brain-targeted piperine solid lipid nanoparticles in an experimentally induced Alzheimer\u2019s disease model. J. Drug Target. 21, 300\u2013311.","DOI":"10.3109\/1061186X.2012.747529"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_180_w2aab3b7c33b1b6b1ab2b1d179Aa","doi-asserted-by":"crossref","unstructured":"Yusuf, M., Khan, M., Khan, R.A., Maghrabi, I.A., and Ahmed, B. (2016). Polysorbate-80-coated, polymeric curcumin nanoparticles for in vivo anti-depressant activity across BBB and envisaged biomolecular mechanism of action through a proposed pharmacophore model. J. Microencap. 33, 646\u2013655.","DOI":"10.1080\/02652048.2016.1242666"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_181_w2aab3b7c33b1b6b1ab2b1d180Aa","doi-asserted-by":"crossref","unstructured":"Zabel, M.K. and Kirsch, W.M. (2013). From development to dysfunction: Microglia and the complement cascade in CNS homeostasis. Ageing Res. Rev. 12, 749\u2013756.","DOI":"10.1016\/j.arr.2013.02.001"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_182_w2aab3b7c33b1b6b1ab2b1d181Aa","doi-asserted-by":"crossref","unstructured":"Zhao, N., Liu, C.-C., Qiao, W., and Bu, G. (2017). Apolipoprotein E, receptors, and modulation of Alzheimer\u2019s disease. Biol. Psychiatry 83, 347\u2013357.","DOI":"10.1016\/j.biopsych.2017.03.003"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_183_w2aab3b7c33b1b6b1ab2b1d182Aa","doi-asserted-by":"crossref","unstructured":"Zsurka, G. and Kunz, W.S. (2010). Mitochondrial dysfunction in neurological disorders with epileptic phenotypes. J. Bioenerg. Biomembr. 42, 443\u2013448.","DOI":"10.1007\/s10863-010-9314-7"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_184_w2aab3b7c33b1b6b1ab2b1d183Aa","doi-asserted-by":"crossref","unstructured":"Zsurka, G., Baron, M., Stewart, J.D., Kornblum, C., B\u00f6s, M., Sassen, R., Taylor, R.W., Elger, C.E., Chinnery, P.F., and Kunz, W.S. (2008). Clonally expanded mitochondrial DNA mutations in epileptic individuals with mutated DNA polymerase \u03b3. J. Neuropathol. Exp. Neurol. 67, 857\u2013866.","DOI":"10.1097\/NEN.0b013e3181839b2d"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_185_w2aab3b7c33b1b6b1ab2b1d184Aa","doi-asserted-by":"crossref","unstructured":"Zsurka, G., Hampel, K., Nelson, I., Jardel, C., Mirandola, S., Sassen, R., Kornblum, C., Marcorelles, P., Lavou\u00e9, S., and Lomb\u00e8s, A. (2010). Severe epilepsy as the major symptom of new mutations in the mitochondrial tRNAPhe gene. Neurology 74, 507\u2013512.","DOI":"10.1212\/WNL.0b013e3181cef7ab"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_186_w2aab3b7c33b1b6b1ab2b1d185Aa","doi-asserted-by":"crossref","unstructured":"Zuchner, T., Schliebs, R., and Perez-Polo, J.R. (2005). Down-regulation of muscarinic acetylcholine receptor M2 adversely affects the expression of Alzheimer\u2019s disease-relevant genes and proteins. J. Neurochem. 95, 20\u201332.","DOI":"10.1111\/j.1471-4159.2005.03335.x"},{"key":"2026080509241277460_j_hsz-2017-0250_ref_187_w2aab3b7c33b1b6b1ab2b1d186Aa","doi-asserted-by":"crossref","unstructured":"Zuchora, B., Turski, W.A., Wielosz, M., and Urbaska, E.M. (2001). Protective effect of adenosine receptor agonists in a new model of epilepsy seizures evoked by mitochondrial toxin, 3-nitropropionic acid, in mice. Neurosci. Lett. 305, 91\u201394.","DOI":"10.1016\/S0304-3940(01)01816-X"}],"container-title":["Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/bchm.2018.399.issue-4\/hsz-2017-0250\/hsz-2017-0250.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hsz-2017-0250\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hsz-2017-0250\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:25:45Z","timestamp":1785921945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hsz-2017-0250\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,20]]},"references-count":186,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,12,20]]},"published-print":{"date-parts":[[2018,3,28]]}},"alternative-id":["10.1515\/hsz-2017-0250"],"URL":"https:\/\/doi.org\/10.1515\/hsz-2017-0250","relation":{},"ISSN":["1437-4315","1431-6730"],"issn-type":[{"value":"1437-4315","type":"electronic"},{"value":"1431-6730","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12,20]]}}}